Education
About Us
Working with TipRanks
Follow Us
BioHarvest Sciences (BHST)
NASDAQ:BHST
BHST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.66 - $9.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)23.48K
Market Cap
$152.71M
Enterprise Value$135.54M
Total Cash (Recent Filing)$3.73M
Total Debt (Recent Filing)$21.09M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Dec 01, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding17,333,430
10 Day Avg. Volume28,598
30 Day Avg. Volume23,476
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue4.49
Enterprise Value/Gross Profit7.74
Enterprise Value/Ebitda-23.28
Forecast
1Y Price Target
$11.67Price Target Upside28.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Digital TransformationManagement's investment in digital transformation and automation should enable BHST to develop new plant-based compounds more efficiently and capture additional market opportunities.
Market PositioningThe company remains very well positioned to capitalize on the growing consumer shift towards wellness, health, and nutrition with its proprietary product development.
Revenue StreamThe new AI discovery service provides a new revenue stream and potentially deepens the pipeline by improving conversion.
Bears Say
Revenue GuidanceThe 3Q25 revenue guidance is below prior consensus and previous estimates.
Tariff HeadwindsManagement highlighted that any tariff headwinds will be managed through cost efficiencies to meet its profitability goals.
BioHarvest Sciences News
BHST FAQ
What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was $4.66 and its highest was $9.90 in the past 12 months.
What is BioHarvest Sciences’s market cap?
BioHarvest Sciences’s market cap is $152.71M.
When is BioHarvest Sciences’s upcoming earnings report date?
BioHarvest Sciences’s upcoming earnings report date is Dec 01, 2025 which is in 75 days.
How were BioHarvest Sciences’s earnings last quarter?
BioHarvest Sciences released its earnings results on Aug 11, 2025. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.13.
Is BioHarvest Sciences overvalued?
According to Wall Street analysts BioHarvest Sciences’s price is currently Undervalued.
Does BioHarvest Sciences pay dividends?
BioHarvest Sciences does not currently pay dividends.
What is BioHarvest Sciences’s EPS estimate?
BioHarvest Sciences’s EPS estimate is -0.12.
How many shares outstanding does BioHarvest Sciences have?
BioHarvest Sciences has 17,333,430 shares outstanding.
What happened to BioHarvest Sciences’s price movement after its last earnings report?
BioHarvest Sciences reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went up 0.685%.
Which hedge fund is a major shareholder of BioHarvest Sciences?
Currently, no hedge funds are holding shares in BHST
BioHarvest Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.67 (28.52% Upside)
$11.67 (28.52% Upside)
Blogger Sentiment
Neutral
BHST Sentiment 100%
Sector Average 66%
Sector Average 66%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.37%
12-Months-Change
Fundamentals
Return on Equity
-973.22%
Trailing 12-Months
Asset Growth
2.90%
Trailing 12-Months
Company Description
BioHarvest Sciences
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
BHST Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, gross margin expansion, and success in both product and CDMO divisions, indicating strong operational momentum. However, increased operating expenses and net losses present challenges. The launch of new products and strategic programs, such as the Health Pros' Affiliate program, are positive indicators for future growth.View all BHST earnings summariesBHST Stock 12 Month Forecast
Average Price Target
$11.67
▲(28.52% Upside)
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---